tradingkey.logo
tradingkey.logo
Search

Co-Diagnostics Inc

CODX
Add to Watchlist
2.990USD
-0.090-2.92%
Close 07/02, 13:00ETQuotes delayed by 15 min
10.77MMarket Cap
LossP/E TTM

Co-Diagnostics Inc

2.990
-0.090-2.92%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

-2.92%

5 Days

-2.29%

1 Month

-48.09%

6 Months

-46.22%

Year to Date

+1673.43%

1 Year

+979.42%

Key Figures
3.010Open
3.400High
1.00MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
27.89%Turnover Ratio
3.080Prev. Close
2.930Low
2.29MTurnover
LossP/E Static
0.67P/B
0.00%Div Yield TTM
-128.83%ROA
46.50052wk High
1.03Volume Ratio
-37.64MNet Profit
3.60MShares
-1054.6482EPS TTM
2.91Beta
-154.38%ROE
1.26052wk Low
15.26%Amplitude
-207.78%Gross Margin
10.77MMarket Cap
-3.56Reward/Risk
13.05%Risk Rate

TradingKey Stock Score of Co-Diagnostics Inc

Currency: USD Updated: 2026-07-02

Key Insights

Co-Diagnostics Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 122 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Co-Diagnostics Inc's Score

Industry at a Glance

Industry Ranking
122 / 204
Overall Ranking
295 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Co-Diagnostics Inc Highlights

StrengthsRisks
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Growing
The company is in a growing phase, with the latest annual income totaling USD 622.49K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 622.49K.
Overvalued
The company’s latest PE is -0.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 248.15K shares, decreasing 39.01% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.73.

Analyst Rating

Based on 2 analysts
Hold
Current Rating
30.000
Target Price
+1171.19%
Upside Space

Co-Diagnostics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Co-Diagnostics Inc Info

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Ticker SymbolCODX
CompanyCo-Diagnostics Inc
CEOEgan (Dwight H)
Websitehttps://codiagnostics.com/

FAQs

What is the current price of Co-Diagnostics Inc (CODX)?

The current price of Co-Diagnostics Inc (CODX) is 2.99.

What is the symbol of Co-Diagnostics Inc?

The ticker symbol of Co-Diagnostics Inc is CODX.

What is the 52-week high of Co-Diagnostics Inc?

The 52-week high of Co-Diagnostics Inc is 46.50.

What is the 52-week low of Co-Diagnostics Inc?

The 52-week low of Co-Diagnostics Inc is 1.26.

What is the market capitalization of Co-Diagnostics Inc?

The market capitalization of Co-Diagnostics Inc is 10.77M.

Is Co-Diagnostics Inc (CODX) currently rated as Buy, Hold, or Sell?

According to analysts, Co-Diagnostics Inc (CODX) has an overall rating of signal_hold, with a price target of 30.00.

What is the Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX)?

The Earnings Per Share (EPS TTM) of Co-Diagnostics Inc (CODX) is -1057.64.